{
  "report_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.68 vs. cons $1.64",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.90B vs. cons $1.91B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Reported gross margin",
      "prediction": "MISS",
      "answer": "pred ~41.2% vs. cons 41.8%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$6.20 vs. cons $6.03 (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales",
      "prediction": "BETTER",
      "answer": "guide ~$7.55B vs. cons $7.52B (FY2027)",
      "confidence": "LOW"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "LOWER",
      "answer": "guide ~1.0% vs. cons 1.3% (FY2027)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Gross-margin change",
      "prediction": "LOWER",
      "answer": "guide ~+70 bps vs. cons +110 bps (FY2027)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "The modest EPS beat and FY2027 EPS framework of ~$6.20 versus ~$6.03 consensus should support upward out-period revisions, as the ~$0.90 ERP comparison reversal becomes visible in estimates. Follow-through is capped by weaker gross-margin guidance (~+70 bps versus +110 bps consensus) and only ~1.0% underlying organic growth.",
  "day5_confidence": "MEDIUM"
}